ResMed Inc. (CHESS) Company Profile (ASX:RMD)

About ResMed Inc. (CHESS)

ResMed Inc. (CHESS) logoResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: ASX
  • Symbol: RMD
  • CUSIP:
Key Metrics:
  • Previous Close: $6.86
  • 50 Day Moving Average: $8.94
  • 200 Day Moving Average: $8.16
  • Trailing P/E Ratio: 36.35
  • P/E Growth: 2.15
  • Market Cap: $12.73B
Additional Links:

Analyst Ratings

Consensus Ratings for ResMed Inc. (CHESS) (ASX:RMD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ResMed Inc. (CHESS) (ASX:RMD)
DateFirmActionRatingPrice TargetDetails
3/16/2015Deutsche Bank AGReiterated RatingHoldView Rating Details
(Data available from 8/29/2014 forward)


Earnings History for ResMed Inc. (CHESS) (ASX:RMD)
No earnings announcements for this company have been tracked by


Earnings Estimates for ResMed Inc. (CHESS) (ASX:RMD)
No earnings estimates for this company have been tracked by


Dividend History for ResMed Inc. (CHESS) (ASX:RMD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for ResMed Inc. (CHESS) (ASX:RMD)
No insider trades for this company have been tracked by


Latest Headlines for ResMed Inc. (CHESS) (ASX:RMD)
DateHeadline logoF&P Healthcare to 'vigorously contest' what's likely to be lengthy IP legal spat (ASX:RMD) - August 23 at 7:18 PM logoResMed (RMD) Stock Slides, Jefferies Downgrades to 'Underperform' (ASX:RMD) - August 23 at 7:18 PM logoETF’s with exposure to ResMed, Inc. : August 18, 2016 (ASX:RMD) - August 18 at 7:24 PM logoETF’s with exposure to ResMed, Inc. : August 5, 2016 (ASX:RMD) - August 5 at 7:24 PM logoLook at Medical Product Earnings on Jul 28: BSX, RMD & More (ASX:RMD) - July 27 at 6:59 AM logoThe easy way to start building a $1 million share portfolio in FY 2017 (ASX:RMD) - July 20 at 10:00 AM logoIs Nanosonics Ltd a blue-chip share of tomorrow? (ASX:RMD) - May 31 at 8:48 AM logoResMed books mixed third-quarter results (ASX:RMD) - April 26 at 8:45 PM logoResMed Q3 revenue up 7 pct (ASX:RMD) - April 26 at 7:42 PM logoResMed misses 3Q profit forecasts (ASX:RMD) - April 26 at 5:29 PM logoResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2016 (ASX:RMD) - April 26 at 4:14 PM logoResMed Files Patent Infringement Action Against BMC and 3B CPAP Devices (ASX:RMD) - April 15 at 5:07 PM logoResMed: Strong Cash Balance, Product Portfolio Drive Growth (ASX:RMD) - April 8 at 2:50 PM logoResMed (RMD) Stock Gets 'Underweight' Rating at Barclays (ASX:RMD) - April 7 at 9:17 AM logoResMed (RMD) Announces Completion of Inova Labs Acquisition (ASX:RMD) - February 4 at 2:36 PM logoWhy AGL Energy Ltd & Fisher & Paykel Healthcare Corp Ltd could offer growth & income (ASX:RMD) - February 3 at 7:19 PM logoResMed Inc. (RMD) Jumped To A 6-Week High On Strong Q2 Earnings (ASX:RMD) - January 25 at 1:15 PM logoWhy ResMed Inc's Stock Is Up Big Today (ASX:RMD) - January 22 at 12:17 PM logoResmed lifts 2Q revenue 7% to $US454.5m (ASX:RMD) - January 21 at 5:50 PM logoResMed tops Street 2Q forecasts (ASX:RMD) - January 21 at 4:46 PM logoResMed (RMD) Stock Downgraded at Barclays (ASX:RMD) - January 19 at 4:19 PM


Last Updated on 8/29/2016 by Staff